Cardiovascular medications and treatment outcomes in multiple myeloma: insights from phase III clinical trials

Citation:

Abuhelwa AY, Almansour SA, Al-Shamsi HO, et al. Sci Rep. 2026 Feb 7;16(1):7683. PMID: 41651961; PMCID: PMC12946163.